Theodor W. Guentert - Concepedia

Author

Theodor W. Guentert

University of California, San Francisco

Also Known As

T GUENTERT, THEODOR W. GUENTERT, Theodor Guentert, Theodor W Guentert, Theodor W. Guentert, Theodor Walter Guentert

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco Roche (Switzerland)University of California System University of Basel University of California San Francisco Medical Center

About

Theodor W. Guentert is an author at University of California, San Francisco specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	755
2	Biochemistry	4	4	86
3	Natural Sciences	2	2	52
4	Education	1	1	22
5	Health Sciences	1	1	82

Theodor W. Guentert

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: A panel study* Lars F. Gram, Theodor W. Guentert, Susan Grange, Clinical Pharmacology & Therapeutics	1995	99
Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adults Robert A. Upton, J. F. Thiercelin, Theodor W. Guentert, Journal of Pharmacokinetics and Biopharmaceutics Theophylline PharmacokineticsPharmacokinetic ModelingHealthy Young AdultsIntraindividual VariabilityMedicine	1982	83
Influence of isolation procedure, extracellular matrix and dexamethasone on the regulation of membrane transporters gene expression in rat hepatocytes Olivier Luttringer, Frank-Peter Theil, Thierry Lavé, Biochemical Pharmacology Cell PhysiologySignal TransductionRat HepatocytesLiver PhysiologyMembrane Transport	2002	82
Convenient and sensitive high-performance liquid chromatography assay for ketoprofen, naproxen and other allied drugs in plasma or urine Robert A. Upton, Jean N. Buskin, Theodor W. Guentert, Journal of Chromatography A Pharmaceutical ScienceMedicineOther Allied DrugsBioanalysisDrug Purity	1980	79
Physiologically Based Pharmacokinetic (PBPK) Modeling of Disposition of Epiroprim in Humans Olivier Luttringer, Frank‐Peter Theil, Patrick Poulin, Journal of Pharmaceutical Sciences Pharmacokinetic ModelingPharmacodynamicsMedicinePhysiologyPharmacotherapy	2003	75
Quinidine pharmacokinetics in man: Choice of a disposition model and absolute bioavailability studies Theodor W. Guentert, Nicholas H. G. Holford, Peter E. Coafes, Journal of Pharmacokinetics and Biopharmaceutics Pharmacological StudyDisposition ModelPharmacologyNeuropharmacologyPharmacotherapy	1979	63
Determination of Quinidine and its major metabolites by high-performance liquid chromatography Theodor W. Guentert, Peter E. Coates, Robert A. Upton, Journal of Chromatography B Biomedical Sciences and Applications Gas ChromatographyMedicineBioanalysisMass SpectrometryAnalytical Chemistry	1979	61
Comparison of Equilibrium Times in Dialysis Experiments Using Spiked Plasma or Spiked Buffer Theodor W. Guentert, Svein Øie Journal of Pharmaceutical Sciences HemodialysisUrologyRenal FunctionMedicineDialysis Therapy	1982	59
Effect of saturable binding on the pharmacokinetics of drugs: a simulation Svein Øie, Theodor W. Guentert, Thomas N. Tozer Journal of Pharmacy and Pharmacology	1980	45
Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria Robert A. Upton, Lloyd Sansom, Theodor W. Guentert, Journal of Pharmacokinetics and Biopharmaceutics Bioavailability CriteriaCommercial Theophylline ProductsBioequivalencePharmacologyMedicine	1980	44

Page 1